Galanin and galanin receptors in human cancers

Alexandra Berger1, Radmila Santic, Cornelia Hauser-Kronberger

  • 1Department of Pediatrics, Paracelsus Private Medical University, Salzburg, Muellner-Hauptstrasse 48, A-5020 Salzburg, Austria.

Neuropeptides
|June 10, 2005
PubMed

Insights

Galanin peptide and its receptors are commonly found in human neuroendocrine tumors like gliomas and pheochromocytomas. This co-expression suggests galanin plays a role in tumor cell growth through autocrine/paracrine signaling.

Area of Science:

  • Oncology
  • Neuroendocrinology
  • Molecular Biology

Background:

  • Peptide receptors are frequently expressed in human tumors, offering potential for targeted therapies.
  • Galanin, a neuropeptide, is implicated in neuroendocrine tumor development, supported by studies in estrogen-sensitive rats.

Purpose of the Study:

  • To review the expression of galanin peptide and its receptors in various human neuroendocrine tumors.
  • To evaluate the potential role of galanin signaling in neuroendocrine tumor pathology.

Main Methods:

  • Literature review of studies investigating galanin and galanin receptor expression.
  • Analysis of expression patterns in human gliomas, pheochromocytomas, pituitary tumors, and neuroblastic tumors.

Main Results:

  • Galanin peptide and its corresponding receptors are commonly expressed in human gliomas, pheochromocytomas, pituitary tumors, and neuroblastic tumors.
  • Co-expression of galanin and its receptors is a frequent observation across these tumor types.

Conclusions:

  • The co-expression of galanin and its receptors in neuroendocrine tumors supports a significant role for galanin in tumor cell pathology.
  • Autocrine and/or paracrine mechanisms involving galanin signaling are likely involved in the progression of these tumors.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...